Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 26,701 | 40,235 | 53,504 |
| Marketable Securities | 81,307 | 145,193 | 23,467 |
| Receivables | 67 | 146 | 1,758 |
| TOTAL | $112,666 | $188,631 | $79,821 |
| Non-Current Assets | |||
| PPE Net | 6,618 | 6,370 | 8,096 |
| Other Non-Current Assets | 11,656 | 14,580 | 17,197 |
| TOTAL | $18,274 | $20,950 | $25,293 |
| Total Assets | $130,940 | $209,581 | $105,114 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 355 | 1,121 | 614 |
| Accrued Expenses | 9,600 | 7,392 | 8,017 |
| Other current liabilities | 73 | N/A | N/A |
| TOTAL | $13,087 | $12,253 | $12,227 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 7,883 | 10,643 | 254,902 |
| TOTAL | $7,883 | $10,687 | $254,902 |
| Total Liabilities | $20,970 | $22,940 | $267,129 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 24,717 | 24,363 | N/A |
| Common Shares | 3 | 3 | N/A |
| Retained earnings | -330,549 | -246,684 | -181,311 |
| Other shareholders' equity | 103 | -129 | 308 |
| TOTAL | $109,970 | $186,641 | $-162,015 |
| Total Liabilities And Equity | $130,940 | $209,581 | $105,114 |